STOCK TITAN

Pressure Bio Stock Price, News & Analysis

PBIO OTC

Welcome to our dedicated page for Pressure Bio news (Ticker: PBIO), a resource for investors and traders seeking the latest updates and insights on Pressure Bio stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Pressure Bio's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Pressure Bio's position in the market.

Rhea-AI Summary

Pressure BioSciences, Inc. (OTCQB: PBIO) will host a teleconference on April 21, 2021, at 4:30 PM ET to discuss its Q4 FY 2020 financial results and provide a business update. Interested parties can listen live or access a replay starting April 22, 2021. The company focuses on pressure-based solutions for the life sciences, leveraging patented technologies like Pressure Cycling Technology and Ultra Shear Technology for various applications, including biopharma and food preservation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.98%
Tags
-
Rhea-AI Summary

Pressure BioSciences, Inc. (PBIO) has executed a letter of intent to acquire an internationally-based eco-friendly agrochemical supplier. This strategic acquisition is expected to enable PBIO to enter the growing agrochemical market, offering alternatives to synthetic pesticides and fertilizers. The company anticipates this acquisition will be accretive, driving significant revenue growth and profitability by Q4 2021. PBIO's Ultra Shear Technology will enhance product effectiveness, targeting the booming organic and sustainable agriculture sectors, poised for growth from $84.5 billion in pesticides by 2023 to $131 billion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Pressure BioSciences (OTCQB: PBIO) announced a strategic partnership with Ohio State University to form a food industry consortium. The consortium will allow members to access PBI's Ultra Shear Technology (UST) for enhancing liquid food products' quality and longevity. Members will benefit from first look access to UST developments and opportunities for licensing. Key goals include improving product safety and extending shelf life while reducing processing costs. The global high-pressure processing market was valued at $15.5 billion in 2019, indicating significant growth and potential for UST as a superior alternative.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.33%
Tags
none
Rhea-AI Summary

Pressure BioSciences, Inc. (PBIO) has partnered with The Ohio State University to create a food industry consortium aimed at advancing its Ultra Shear Technology (UST). The consortium will utilize UST in Ohio State's food pilot plant, focusing on developing innovative food applications and addressing regulatory concerns. Members will have first rights to license new UST applications. The initiative, backed by USDA funding, aims to enhance food safety, stabilize products for ambient storage, and improve overall quality. The global high-pressure processing market was valued at $15.5 billion in 2019, reflecting growth potential.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.17%
Tags
none
-
Rhea-AI Summary

On February 24, 2021, Pressure BioSciences (OTCQB: PBIO) announced a partnership with Ohio State University to establish a food industry consortium aimed at advancing its Ultra Shear Technology (UST). This consortium will utilize UST for developing innovative food applications that improve safety, quality, and nutrition. Members will have access to UST systems and the right to license new applications. The initiative is supported by USDA NIFA funding and aims at enhancing liquid food processing efficiency while reducing costs and extending shelf life.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.17%
Tags
none
-
Rhea-AI Summary

Pressure BioSciences, Inc. (OTCQB: PBIO) has signed a letter of intent to acquire assets from a globally recognized supplier of eco-friendly agrochemicals. This acquisition aims to capitalize on the increasing demand for alternatives to synthetic pesticides and fertilizers driven by global population growth and environmental sustainability. The company's Ultra Shear Technology™ (UST™) is expected to enhance the bioavailability of these agrochemicals. The global pesticides market is projected to grow from $84.5 billion in 2019 to $131 billion by 2023, while fertilizers are expected to reach $232 billion by 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.36%
Tags

FAQ

What is the current stock price of Pressure Bio (PBIO)?

The current stock price of Pressure Bio (PBIO) is $0.0005 as of March 5, 2026.

What is the market cap of Pressure Bio (PBIO)?

The market cap of Pressure Bio (PBIO) is approximately 4.1K.

PBIO Rankings

PBIO Stock Data

4.10k
40.63M
Medical Devices
Healthcare
Link
United States
Canton

PBIO RSS Feed